AGP Picks
View all

Health Channel of Togo
Provided by AGP

Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
17 minutes ago

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
29 minutes ago

Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire
CervoMed to Participate in September Investor Conferences
29 minutes ago

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
29 minutes ago

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
BioVie Announces Update to Parkinson’s Phase 3 Development Program
29 minutes ago

BioVie Announces Update to Parkinson’s Phase 3 Development Program

Indeterminate GlobeNewswire
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
29 minutes ago

BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

Indeterminate GlobeNewswire
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
29 minutes ago

BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™

Indeterminate GlobeNewswire
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
29 minutes ago

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
29 minutes ago

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Indeterminate GlobeNewswire
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
29 minutes ago

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Indeterminate GlobeNewswire
Generate Biomedicines Inc. to Participate in September Investor Conferences
an hour ago

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
an hour ago

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming September Investor Conferences
an hour ago

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
an hour ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
an hour ago

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
an hour ago

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
an hour ago

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
an hour ago

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
an hour ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire
Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
an hour ago

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Channel of Togo

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.